To explore possible mechanisms by which complement membrane attack complexes (MAC) These results demonstrate that glomerular mesangial cell membrane interaction with the MAC stimulates the production of the toxic oxygen metabolites 0-and H202. Activation of the terminal complement pathway by mesangial immune deposits in vivo might lead to tissue injury by stimulation of local production of toxic oxygen-free radicals.
Introduction
The complement system is well established as an important mediator of immune renal disease (1) (2) (3) Receivedfor publication 29 July 1985 and in revisedform 17 October 1985. (GBM)' antibody-induced glomerulonephritis have elucidated an indirect role for complement acting through chemotactic (C5a) or immune adherence (C3b) mechanisms to attract circulating inflammatory cells that have been shown to be the principal mediators of tissue injury and proteinuria in these models (2) (3) (4) (5) . We have documented an additive direct effect of complement in mediating proteinuria induced by the in situ formation of subepithelial immune complexes that involve both endogenous cell membrane and exogenous planted antigens (6, 7) . In these models of experimental membranous nephropathy, there is no participation of inflammatory cells, and the pathogenic mechanism has been postulated to involve instead the assembly of the complement membrane attack complex (C5b- 9 [MAC]) (6, 7) . Support for this hypothesis has been derived from subsequent studies demonstrating a requirement for C6 in the production ofglomerular injury in several models ofimmune glomerular disease (8) (9) (10) . MAC neoantigens have also been demonstrated in glomeruli in various human and experimental glomerular diseases and appear to correlate with complementdependent glomerular injury in appropriately studied experimental models (1 .
The mechanism by which the MAC produces glomerular injury is not known. Recent studies suggest that reactive oxygen metabolites (ROM) produced by activated neutrophils are important mediators of glomerular injury in several experimental diseases that are neutrophil-mediated (23-25). Moreover, it has recently been demonstrated that resident glomerular mesangial cells are also capable of producing ROM in response to certain stimuli (26, 27) . This raises the possibility that resident glomerular cells may also participate in the mediation of some glomerular lesions. The MAC has recently been shown to be a potent stimulus to production ofseveral potential inflammatory mediators by glomerular mesangial cells, including prostaglandins and an interleukin 1-like cytokine (28) , and a similar effect of the MAC has been demonstrated in stimulating arachidonic acid metabolism in platelets and macrophages (29, 30) . We therefore tested the hypothesis that the effect of the MAC in producing glomerular disease may involve a similar nonlethal activation of resident glomerular cells to produce ROM. Our findings demonstrate that sublethal quantities of the MAC are a potent stimulus to mesangial cell release of ROM, which may play a role in mediating glomerular lesions that are MAC-dependent.
1. Abbreviations used in this paper: GBM, glomerular basement membrane; GVB-EDTA, 4 
Methods
Mesangial cell culture. Glomeruli were isolated from the kidneys ofmale Sprague-Dawley rats weighing 100-150 g (Tyler Laboratories, Bellevue, WA) using stainless steel sieves, as described previously (31) . After treatment with collagenase (1,200 U/ml; Cooper Biomedical, Malvern, PA) for 30 min at 370C, the glomeruli were plated on culture dishes in RPMI 1640 media containing 15% heat-inactivated fetal calf serum, penicillin (100 U/ml), streptomycin (100 Mg/ml), amphotericin (0.25 Mg/ml), and insulin (0.66 U/ml) (Irvine Scientific, Santa Ana, CA). Cultures were maintained at 370C in 5% CO2 in air and passaged every 7-10 d using trypsin-EDTA (Gibco Laboratories, Santa Clara, CA).
The initial outgrowth from glomeruli consisted of spindle-or stellateshaped cells as described by others (32) . When these cells were passaged they exhibited other characteristics of mesangial cells, including contraction in response to 10-6 M angiotensin II (33 Isolation and purification of C5b6. CSb6 was isolated according to the method ofYamamoto and Gewurz (35) . Briefly, a 20% sodium sulfate precipitate of fresh frozen normal human serum was applied to a column of DEAE-cellulose (Whatman Laboratory Products, Clifton, NJ) in 0.1 M phosphate buffer, pH 7.5, conductance 7.0 millisiemens/cm and eluted with a linear NaCl gradient in the same buffer (7-25 millisiemens/cm). Column fractions were assayed for C5, C6, and C7 hemolytic activity by conventional hemolytic assays ( 11) . Zymosan C5b6 is allowed to react with serum in the absence of cells, a decayed MAC is formed that can no longer bind to cell membranes (37, 38).
In initial experiments to evaluate ROM production by mesangial cells in response to MAC, we removed cells from culture plates with 0.6 mM EDTA, washed twice with KRPG, aliquoted into individual tubes (I0O cells per tube), and assayed°2 production as described below after the addition of the MAC and control stimuli to cells. MAC formation in the presence of mesangial cells was initiated by addition to the cell suspension ofC5b6 (17 U/ml final concentration) followed by fresh normal human serum (NHS) diluted 1:20 with KRPG containing 10 
Results
Cell viability. After exposure to C5b6 plus serum for 30 min, a process that results in the active production ofMACs, 80.2±6.8% (n = four culture plates) ofmesangial cells excluded trypan blue. This was not significantly different from cells exposed to buffer alone (78.5±3.6%, n = 8, P > 0.20) or to decayed C5b-9 complexes incapable ofcell membrane insertion (77.4±4.5%, n = 4, P > 0.20). Similarly, cells exposed to MACs released only 3.8±0.2% (n = 3) of the Cr3' label after 30 min, which was not significantly different from cells exposed to buffer alone (3.2±0.2%, n = 6, P > 0.10) or to decayed complexes (6.3±1.8%, n = 3, P > 0.20 
Discussion
The importance of the C5b-9, or membrane attack portion, of the complement pathway as a direct mediator of glomerular injury has recently been established (43) . A role for the MAC in glomerular injury was first suggested by the observation that proteinuria in experimental models ofmembranous nephropathy induced by in situ immune complex formation, involving both fixed and planted subepithelial antigens, was complement-dependent but inflammatory cell-independent (6, 7). Clarification for this hypothesis derived from studies of animals genetically deficient in or depleted of C6 (8) (9) (10) . Thus, in rabbits with chronic serum sickness induced by repeated injections of cationized bovine serum albumin, proteinuria is reduced in C6-deficient rabbits (8) . The same is true in rabbits with nephritis induced by deposition ofanti-GBM antibody (9) . Finally, in the passive Heymann model of experimental membranous nephropathy in rats, depletion of C6 totally prevents the devel- MACs were always greater than that seen with cells studied in suspension, although the response to decayed MACs was similar under both conditions. This observation, which may reflect some loss of O-producing capacity during removal from the culture plates, prompted us to perform all subsequent experiments on undisturbed cells.
The suggestion that production of ROM by glomerular mesangial cells may be of pathogenic significance is supported by comparisons of the quantities of ROM produced by these cells with those produced by phagocytic leukocytes that are known *p<0.02 to induce ROM-mediated glomerular injury. We (64) , and exposure of GBM and fibronectin to H202 was shown to enhance their susceptibility to proteolysis (65) . With regard to the possible pathogenic significance of MAC stimulation of mesangial cells in human renal disease, small deposits of MAC neoantigens, usually in the absence of immunoglobulins and C3, are found in the mesangium in a wide variety of lesions, many of which are not generally considered to be of immunologic origin, and are also seen in sclerotic areas as well as in normal kidneys (16) (17) (18) (19) (20) . The frequent association of MAC deposits with cell membrane fragments (20) and the capacity of damaged cells to activate complement (66) suggest that the MACs may form locally in the glomerulus rather than being trapped from the circulation. Whether the MAC is pathogenic in the absence of immune deposits is unclear, but the ability of MAC without immune complexes to stimulate production of ROM and other inflammatory mediators by mesangial cells, as described above, might contribute to local injury.
Of particular interest with regard to our studies are the mesangial MAC deposits associated with IgG and C3 in several immune-mediated renal diseases, including lupus (sytemic lupus erythematosus) nephritis, types I and II membrano-proliferative glomerulonephritis, IgA nephropathy, Henoch-Schonlein purpura, and poststreptococcal nephritis (16) (17) (18) (19) (20) (21) (22) . In all these lesions, cellular proliferation and mesangial matrix expansion are typical morphologic findings. These morphologic abnormalities may be linked to the production of inflammatory mediators such as ROM by either endogenous glomerular cells or by infiltrating cells stimulated by exposure to the MAC.
In summary, exposure of rat glomerular mesangial cells in culture to MAC stimulates the production of the reactive oxygen metabolites Q-and H202. These highly reactive molecules are known to contribute to glomerular injury induced by circulating inflammatory cells and may therefore be pathogenic when released locally by resident glomerular cells. The common finding ofMAC neoantigen localization in the mesangium in many human and experimental renal diseases is consistent with the suggestion that a similar phenomena may occur in vivo and could contribute to the production of glomerular injury through any ofthe mechanisms outlined above. These studies, therefore, define a new mechanism that may relate to the established pathogenic role of the terminal complement pathway in mediating several forms of immune glomerular disease.
